Human prothrombin complex - Shanxi Kangbao Biological Product
Latest Information Update: 14 Jan 2016
At a glance
- Originator Shanxi Kangbao Biological Product
- Class Blood coagulation factors
- Mechanism of Action Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Prothrombin stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Haemorrhage; Surgical blood loss
Most Recent Events
- 14 Jan 2016 Clinical trials in Haemorrhage in China (IV) prior to January 2016 (Shanxi Kangbao Biological Product pipeline, January 2016)
- 14 Jan 2016 Clinical trials in Surgical blood loss in China (IV) prior to January 2016 (Shanxi Kangbao Biological Product pipeline, January 2016)